Dengue vaccine clinical trials in India - An opportunity to inform the global response to a re-emerging disease challenge

Affiliations

¹ National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), USA. Electronic address: afauci@niaid.nih.gov.
² Division of Microbiology and Infectious Diseases, NIAID, NIH, USA. Electronic address: emily.erbelding@nih.gov.
³ Laboratory of Infectious Diseases, NIAID, NIH, USA. Electronic address: swhitehead@niaid.nih.gov.
⁴ Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH, USA. Electronic address: ccassetti@niaid.nih.gov.
⁵ Office of the Director, NIAID, NIH, USA. Electronic address: handleygr@niaid.nih.gov.
⁶ Office of Global Research, NIAID, NIH, USA. Electronic address: guptar@niaid.nih.gov.

Free article

Editorial

Anthony Fauci et al. Int J Infect Dis. 2019 Jul.

Free article

. 2019 Jul:84S:S4-S6.

doi: 10.1016/j.ijid.2019.03.016. Epub 2019 Mar 14.

¹ National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), USA. Electronic address: afauci@niaid.nih.gov.
² Division of Microbiology and Infectious Diseases, NIAID, NIH, USA. Electronic address: emily.erbelding@nih.gov.
³ Laboratory of Infectious Diseases, NIAID, NIH, USA. Electronic address: swhitehead@niaid.nih.gov.
⁴ Virology Branch, Division of Microbiology and Infectious Diseases, NIAID, NIH, USA. Electronic address: ccassetti@niaid.nih.gov.
⁵ Office of the Director, NIAID, NIH, USA. Electronic address: handleygr@niaid.nih.gov.
⁶ Office of Global Research, NIAID, NIH, USA. Electronic address: guptar@niaid.nih.gov.

No abstract available

Publication types